Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Perrigo Expects Retailers Will 'Push' OTC Private Label Market Share Growth

Executive Summary

Perrigo sees continued upside for digital sales of private label, given a “push marketing” approach that presents product ads to consumers shopping for branded products online, says CFO Ronald Winoweiecki. He also says the firm has not reached a decision on whether to divest its Rx generics business.


Related Content

Amazon OTC Line's Impact On Pricing Grows Along With Its SKUs
Sensitivity To Flu Helped OTC Drug Firms End 2017 With Sales Boost
Perrigo ANDA Approval Brings New Options To Generic Mucinex DM Maximum Strength Portfolio
Perrigo Finding Balance As Three-Legged Stool With Two Consumer Units, Rx Division
Amazon OTCs Likely A Worry For Retailers, A Remedy For Perrigo


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts